1. Oligometastatic head and neck cancer: Comprehensive review
- Author
-
Xiaoshan Z. Gordy, Divyang Mehta, Toms Vengaloor Thomas, Srinivasan Vijayakumar, Anu Abraham, Satyaseelan Packianathan, Eldrin Bhanat, Ashley Albert, and M.R. Kanakamedala
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,MEDLINE ,Radiosurgery ,Primary disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Humans ,Medicine ,Basal cell ,Head and neck ,Retrospective Studies ,business.industry ,Head and neck cancer ,Metastasectomy ,Prognosis ,medicine.disease ,stomatognathic diseases ,030104 developmental biology ,Otorhinolaryngology ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Stereotactic body radiation ,business - Abstract
There are limited data available regarding the management of oligometastatic squamous cell carcinoma of the head and neck (SCCHN) patients, and no consensus guidelines are available. The objective is to review the available literature for the management of oligometastatic SCCHN. Articles were selected from English Medline literature between 1995 and 2018, searched by using the keywords: oligometastatic SCCHN/metastasectomy/stereotactic body radiation treatment (SBRT). With the available data, oligometastatic SCCHN patients appear to behave differently and tend to have a better prognosis than those with widespread metastases. Retrospective evidence suggests that the aggressive treatment of the primary disease and local treatment of the metastatic sites improves survival in oligometastatic SCCHN at diagnosis. The definitive treatment of the distant metastatic sites using metastasectomy or SBRT correlates with better survival in oligorecurrent patients. Oligometastatic SCCHN patients may have a better prognosis if treated aggressively.
- Published
- 2020
- Full Text
- View/download PDF